About Axordia
Axordia is one of the UK’s leading human embryonic stem cell (hESC) companies. It has a unique portfolio of patent protected technologies and proprietary materials - GMP derived hESC lines; the capacity to produce key cell line derivatives, including a patent protected endovascular line with powerful potential; RNA interference (RNAi); Wnt and Notch signalling; a suite of hESC biomarkers.
Based in Sheffield and with strong links to the University of Sheffield, the UK’s leading university in the generation of stem cell related IP, Axordia Is focussed on the delivery of a range of novel cells and kits that will enable drug discovery and the production of quality-assured cells for transplantation to patients suffering degenerative disease and injury.
Axordia is developing and commercialising products in three areas
* Drug discovery tools that will support traditional and new generation drug discovery using hESC and key cell lines derived from hESC.
* Therapeutic treatments derived from hESC covering transplantation, cardio-vascular disease, diabetes and Parkinson’s
* Technologies and materials that will support the rapid and successful development effective products by the hESC industry
- Focus : Manufacturer
- Industry : Biotechnology
